Nanocrine was founded to bring a revolutionary technology, initially developed by the US Department of the Navy, to the life science community for the purpose of advancing fundamental knowledge of human health and disease.

Our proprietary microscopy technology allows researchers to detect and map molecules secreted by individual cells with spatial and temporal precision — something never before achievable with conventional tools such as ELISA or bulk assays.

By directly observing how cells communicate and influence their environment in real time, our platform opens new frontiers in understanding disease biology and therapeutic response. This capability is especially powerful in complex contexts such as the tumor microenvironment, wound healing, and stem cell biology, where the behavior of individual cells drives critical outcomes.

Our mission is to equip scientists and clinicians with tools that accelerate discovery and enable more effective treatments. By bridging the gap between cellular activity and molecular readouts, we aim to transform how diseases are studied, how drugs are developed, and ultimately how patients are treated.

Founded by scientists with deep expertise in cell biology, microscopy, and translational research, Nanocrine is driven by the belief that better biological understanding leads to better medicine. We are committed to pushing the boundaries of technology to reveal insights that were once hidden, and to partnering with researchers who share our vision of a healthier future.

Our headquarters and laboratory are located in Frederick, Maryland. Our multidisciplinary team of physicists, engineers, and cell biologists work together to make our next-gen imaging platform possible.